Publications dans lesquelles il/elle collabore avec MYRIAM SAÍNZ RAMOS (14)

2024

  1. Hydrogel bioink formulation for 3D bioprinting: Sustained delivery of PDGF-BB and VEGF in biomimetic scaffolds for tendon partial rupture repair

    International Journal of Bioprinting, Vol. 10, Núm. 3, pp. 442-467

2023

  1. 3D Bioprinting for Ocular Applications

    3D Printing and Bioprinting for Pharmaceutical and Medical Applications (CRC Press), pp. 221-245

  2. Assessment of Different Niosome Formulations for Optogenetic Applications: Morphological and Electrophysiological Effects

    Pharmaceutics, Vol. 15, Núm. 7

  3. Erratum: Nanodiamonds Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases (ACS Appl. Mater. Interfaces (2022) 14:11 (13665−13677) DOI: 10.1021/acsami.2c02182)

    ACS Applied Materials and Interfaces

  4. Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior

    Biomolecules, Vol. 13, Núm. 11

  5. Long-term biophysical stability of nanodiamonds combined with lipid nanocarriers for non-viral gene delivery to the retina

    International Journal of Pharmaceutics, Vol. 639

  6. Stability of Monoclonal Antibodies as Solid Formulation for Auto-Injectors: A Pilot Study

    Pharmaceutics, Vol. 15, Núm. 8

2022

  1. Nanodiamond Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases

    ACS Applied Materials and Interfaces, Vol. 14, Núm. 11, pp. 13665-13677

2021

  1. Clay minerals as bioink ingredients for 3d printing and 3d bioprinting: Application in tissue engineering and regenerative medicine

    Pharmaceutics, Vol. 13, Núm. 11

  2. Correlation between biophysical properties of niosomes elaborated with chloroquine and different tensioactives and their transfection efficiency

    Pharmaceutics, Vol. 13, Núm. 11

  3. How far are non‐viral vectors to come of age and reach clinical translation in gene therapy?

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

  4. Sphingolipid extracts enhance gene delivery of cationic lipid vesicles into retina and brain

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 169, pp. 103-112

2020

  1. Niosome-based approach for in situ gene delivery to retina and brain cortex as immune-privileged tissues

    Pharmaceutics, Vol. 12, Núm. 3

  2. Non-viral mediated gene therapy in human cystic fibrosis airway epithelial cells recovers chloride channel functionality

    International Journal of Pharmaceutics, Vol. 588